Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,118
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,793
Class I recallsReasonable probability of serious health consequences
24,343
Class II recallsTemporary or medically reversible health consequences
2,887
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,343
Class I9,793
Class III2,887
Not Yet Classified1

Showing 10,381–10,400 of 17,327 recalls

FDA Recall Terminated Historical recordClass II

Methylcobalamin 10mg, (1mg/ml), 30 mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659, 1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

PF-Glutathione 200mg/ml, 30 mL vials, Rx only, Bella Pharma 3101 W. Devon Ave., Chicago, IL 60659 1 (877) BELLA.

by Bella Pharmaceuticals, Inc.

Reason
Lack of Assurance of Sterility.
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Super Panther 7K Capsules 1250 mg blend, a) 1 count blister cards shipped in boxes of 30 (UPC# 6015577513247); and b) 6 count bottles (UPC# 601577513209), Distributed by SX Power CO., Brooklyn, NY

by Chiavna Saffron LLC

Reason
Marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

New Kopi Jantan Tradisional Natural Herbs Coffee, packaged in 13 gram red packets, and each box contains 25 packets, Made in Malaysia, USA Distributor: Bestherbscoffee LLC (USA), Email: bestherbscoffee@yahoo.com

by BESTHERBS COFFEE LLC

Reason
Marketed without an approved NDA/ANDA: presence of undeclared desmethyl carbodenafil and undeclared milk.
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ninjacof-A (Acetaminophen 160 mg, Chlophedianol HCL 12.5 mg and Pyrilamine Maleate 12.5 mg) Oral Solution, 16 fl. oz. (473 mL), Cotton Candy Flavor, Manufactured for: Centurion Labs, LLC Birmingham, AL 35243 --- NDC 23359-033-16

by Centurion Labs, LLC

Reason
Microbial contamination of Non-sterile Products; potential B. cepacia contamination
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ninjacof (Chlophedianol HCL 12.5 mg and Pyrilamine Maleate 12.5 mg) Oral Solution, 16 fl. oz. (473 mL), Cotton Candy Flavor, Manufactured for: Centurion Labs, LLC Birmingham, AL 35243 --- NDC 23359-032-16

by Centurion Labs, LLC

Reason
Microbial contamination of Non-sterile Products; potential B. cepacia contamination
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Hydrocodone Bitartrate and Acetaminophen Oral Solution 7.5 mg/325 mg per 15 mL (Cherry Flavored), 473 mL bottles, Rx only, Manufactured by: VistaPharm, Inc. Largo, FL 33771 ---- NDC 66689-023-16

by VistaPharm, Inc.

Reason
Labeling: Not Elsewhere Classified; product is incorrectly labeled as Class III controlled substance instead of Class II controlled substance
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Vitamin A&D Ointment (petroleum 93.5%), Skin Protectant, NET Wt. 0.18 OZ (5g), Manufactured for Medline Industries, Inc., Northfield, IL 60093 USA. NDC: 53329-090-16

by Medline Industries Inc

Reason
Labeling Mixup; the individual A&D ointment foil packets are incorrectly labeled as petroleum jelly. The boxes and outer case are correctly labeled as A&D ointment.
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534, NDC 68382-099-06, UPC 3 6838209906 8

by Zydus Pharmaceuticals USA Inc

Reason
Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

AMLODIPINE BESYLATE TABLET, USP, 10 mg, 1000 count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories, LLC Montvale, NJ 07645, NDC 67877-199-10

by Ascend Laboratories LLC

Reason
PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg.
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

The Harvard Drug Group

Product
Leader Liquid Vitamin D Supplement for Breastfed Infants, 1…
Reason
The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

The Harvard Drug Group

Product
Leader Liquid Multivitamin Supplement for Infants and Toddle…
Reason
The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

The Harvard Drug Group

Product
Major Tri-Vita Drops, 1 2/3 oz (50 mL)
Reason
The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

The Harvard Drug Group

Product
Major Poly-Vita Drops with Iron, 1 2/3 oz (50 mL)
Reason
The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

The Harvard Drug Group

Product
Major Poly-Vita Drops, 1 2/3 oz (50 mL)
Reason
The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

The Harvard Drug Group

Product
Major Ferrous Drops, 1 2/3 oz (50 mL)
Reason
The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

The Harvard Drug Group

Product
Major D-Vita Drops, 1 2/3 oz (50 mL)
Reason
The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

The Harvard Drug Group

Product
Major CertaVite Liquid, 8 oz. (236 mL)
Reason
The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

The Harvard Drug Group

Product
Rugby Tri-vitamin Liquid, 1 2/3 oz (50 mL)
Reason
The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.
Published
September 20, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

The Harvard Drug Group

Product
Rugby Polyvitamin Liquid with Iron, 1 2/3 oz (50 mL)
Reason
The distribution firms Leader Brand, Major Pharmaceuticals, and The Harvard Drug Group dba Rugby Laboratories are jointly initiating a voluntary recall of multiple supplements due to possible product contamination with B. cepacia, which may result in serious infections that could be life-threatening in patients with compromised immune systems and in patients with chronic lung conditions such as cystic fibrosis.
Published
September 20, 2017
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.